People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...
Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.
As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...
Health and Me on MSN3d
GLP-1 Drugs Could Be Used To Treat Chronic Kidney DiseaseA latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...
GLP-1 is a hormone made naturally in the gut. It plays a big role in managing blood sugar and appetite while releasing ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback